Transplantation of human islets without immunosuppression

Barbara Ludwig, Andreas Reichel, Anja Steffen, Baruch Zimerman, Andrew V Schally, Norman L Block, Clark K. Colton, Stefan Ludwig, Stephan Kersting, Ezio Bonifacio, Michele Solimena, Zohar Gendler, Avi Rotem, Uriel Barkai, Stefan R. Bornstein

Research output: Contribution to journalArticle

123 Citations (Scopus)

Abstract

Transplantation of pancreatic islets is emerging as a successful treatment for type-1 diabetes. Its current stringent restriction to patients with critical metabolic lability is justified by the long-Term need for immunosuppression and a persistent shortage of donor organs. We developed an oxygenated chamber system composed of immune-isolating alginate and polymembrane covers that allows for survival and function of islets without immunosuppression. A patient with type-1 diabetes received a transplanted chamber and was followed for 10 mo. Persistent graft function in this chamber system was demonstrated, with regulated insulin secretion and preservation of islet morphology and function without any immunosuppressive therapy. This approach may allow for future widespread application of cell-based therapies.

Original languageEnglish
Pages (from-to)19054-19058
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume110
Issue number47
DOIs
StatePublished - Nov 19 2013

Fingerprint

Islets of Langerhans Transplantation
Type 1 Diabetes Mellitus
Immunosuppression
Immunosuppressive Agents
Cell- and Tissue-Based Therapy
Immune System
Tissue Donors
Insulin
Transplants
Survival
Therapeutics
alginic acid

ASJC Scopus subject areas

  • General

Cite this

Transplantation of human islets without immunosuppression. / Ludwig, Barbara; Reichel, Andreas; Steffen, Anja; Zimerman, Baruch; Schally, Andrew V; Block, Norman L; Colton, Clark K.; Ludwig, Stefan; Kersting, Stephan; Bonifacio, Ezio; Solimena, Michele; Gendler, Zohar; Rotem, Avi; Barkai, Uriel; Bornstein, Stefan R.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, No. 47, 19.11.2013, p. 19054-19058.

Research output: Contribution to journalArticle

Ludwig, B, Reichel, A, Steffen, A, Zimerman, B, Schally, AV, Block, NL, Colton, CK, Ludwig, S, Kersting, S, Bonifacio, E, Solimena, M, Gendler, Z, Rotem, A, Barkai, U & Bornstein, SR 2013, 'Transplantation of human islets without immunosuppression', Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 47, pp. 19054-19058. https://doi.org/10.1073/pnas.1317561110
Ludwig, Barbara ; Reichel, Andreas ; Steffen, Anja ; Zimerman, Baruch ; Schally, Andrew V ; Block, Norman L ; Colton, Clark K. ; Ludwig, Stefan ; Kersting, Stephan ; Bonifacio, Ezio ; Solimena, Michele ; Gendler, Zohar ; Rotem, Avi ; Barkai, Uriel ; Bornstein, Stefan R. / Transplantation of human islets without immunosuppression. In: Proceedings of the National Academy of Sciences of the United States of America. 2013 ; Vol. 110, No. 47. pp. 19054-19058.
@article{de47123212504fc6a8ac14655763b25d,
title = "Transplantation of human islets without immunosuppression",
abstract = "Transplantation of pancreatic islets is emerging as a successful treatment for type-1 diabetes. Its current stringent restriction to patients with critical metabolic lability is justified by the long-Term need for immunosuppression and a persistent shortage of donor organs. We developed an oxygenated chamber system composed of immune-isolating alginate and polymembrane covers that allows for survival and function of islets without immunosuppression. A patient with type-1 diabetes received a transplanted chamber and was followed for 10 mo. Persistent graft function in this chamber system was demonstrated, with regulated insulin secretion and preservation of islet morphology and function without any immunosuppressive therapy. This approach may allow for future widespread application of cell-based therapies.",
author = "Barbara Ludwig and Andreas Reichel and Anja Steffen and Baruch Zimerman and Schally, {Andrew V} and Block, {Norman L} and Colton, {Clark K.} and Stefan Ludwig and Stephan Kersting and Ezio Bonifacio and Michele Solimena and Zohar Gendler and Avi Rotem and Uriel Barkai and Bornstein, {Stefan R.}",
year = "2013",
month = "11",
day = "19",
doi = "10.1073/pnas.1317561110",
language = "English",
volume = "110",
pages = "19054--19058",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "47",

}

TY - JOUR

T1 - Transplantation of human islets without immunosuppression

AU - Ludwig, Barbara

AU - Reichel, Andreas

AU - Steffen, Anja

AU - Zimerman, Baruch

AU - Schally, Andrew V

AU - Block, Norman L

AU - Colton, Clark K.

AU - Ludwig, Stefan

AU - Kersting, Stephan

AU - Bonifacio, Ezio

AU - Solimena, Michele

AU - Gendler, Zohar

AU - Rotem, Avi

AU - Barkai, Uriel

AU - Bornstein, Stefan R.

PY - 2013/11/19

Y1 - 2013/11/19

N2 - Transplantation of pancreatic islets is emerging as a successful treatment for type-1 diabetes. Its current stringent restriction to patients with critical metabolic lability is justified by the long-Term need for immunosuppression and a persistent shortage of donor organs. We developed an oxygenated chamber system composed of immune-isolating alginate and polymembrane covers that allows for survival and function of islets without immunosuppression. A patient with type-1 diabetes received a transplanted chamber and was followed for 10 mo. Persistent graft function in this chamber system was demonstrated, with regulated insulin secretion and preservation of islet morphology and function without any immunosuppressive therapy. This approach may allow for future widespread application of cell-based therapies.

AB - Transplantation of pancreatic islets is emerging as a successful treatment for type-1 diabetes. Its current stringent restriction to patients with critical metabolic lability is justified by the long-Term need for immunosuppression and a persistent shortage of donor organs. We developed an oxygenated chamber system composed of immune-isolating alginate and polymembrane covers that allows for survival and function of islets without immunosuppression. A patient with type-1 diabetes received a transplanted chamber and was followed for 10 mo. Persistent graft function in this chamber system was demonstrated, with regulated insulin secretion and preservation of islet morphology and function without any immunosuppressive therapy. This approach may allow for future widespread application of cell-based therapies.

UR - http://www.scopus.com/inward/record.url?scp=84888092380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888092380&partnerID=8YFLogxK

U2 - 10.1073/pnas.1317561110

DO - 10.1073/pnas.1317561110

M3 - Article

C2 - 24167261

AN - SCOPUS:84888092380

VL - 110

SP - 19054

EP - 19058

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 47

ER -